Silver Book Fact

An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.

Duehmke R, Derry S, Wiffen P, Bell R, et al. Tramadol for Treating Neuropathic Pain. Cochrane Database of Systematic Reviews. 2017; 6. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003726.pub4/epdf/abstract

Reference

Title
Tramadol for Treating Neuropathic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2017
Authors
Duehmke R, Derry S, Wiffen P, Bell R, et al.
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.  
  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.  
  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.